Table 1 Expected cost and expected revenue of each project ($ million)
From: Pharmaceutical portfolio optimization under cost uncertainty via chance constrained-type method
Project | Phase | Reg | Expected revenue | |||
|---|---|---|---|---|---|---|
PC | PH1 | PH2 | PH3 | |||
Project 1 | 1 | 7 | 27 | 126 | 7 | 191 |
Project 2 | 1 | 7 | 27 | 101 | 7 | 235 |
Project 3 | – | 5 | 27 | 127 | 7 | 14,205 |
Project 4 | – | 1 | 47 | 63 | 7 | 8100 |
Project 5 | – | – | 22 | 164 | 7 | 955 |
Project 6 | – | – | 11 | 75 | 5 | 744 |
Project 7 | – | – | – | 27 | 7 | 6043 |
Project 8 | 1 | 7 | 27 | 123 | 6 | 179 |
Project 9 | – | – | – | 26 | 6 | 5677 |
Project 10 | – | – | – | 27 | 8 | 13,530 |
Project 11 | – | – | 20 | 155 | 8 | 668 |
Project 12 | – | – | 21 | 164 | 7 | 1036 |
Project 13 | – | – | 27 | 132 | 9 | 1347 |
Project 14 | – | – | 12 | 140 | 9 | 1285 |
Project 15 | 3 | 7 | 32 | 146 | 7 | 259 |